WASHINGTON (Reuters) – U.S. District Judge Aileen Cannon allowed the Justice Department to release its special counsel report on President-elect Donald Trump’s
Investing.com — The administration of U.S. President Joe Biden has determined that China employs unfair policies and practices to gain dominance in
(Reuters) -Allstate has been sued by the state of Texas, which accused the insurer on Monday of illegally tracking drivers through their
(Reuters) – Smartphone shipments for Apple (NASDAQ:AAPL) and Samsung (KS:005930) declined in the fourth quarter globally, as they grapple with intense competition
UK-exposed assets witnessed a significant sell-off on Friday, triggered by a confluence of spillovers from the US bond market and apprehensions regarding
By Tim Hepher DUBLIN (Reuters) – AerCap, the world’s largest aircraft leasing company, said on Monday that potential new trade tariffs floated by
By John Kruzel WASHINGTON (Reuters) – The U.S. Supreme Court declined on Monday to hear a bid by Sunoco and other oil companies
(Reuters) – The Los Angeles wildfires, which have reduced entire neighborhoods to smoldering ruins and left an apocalyptic landscape, could become the
MILAN (Reuters) – An Italian court is expected to decide this week on a request by Telecom Italia (BIT:TLIT)’s (TIM)
Investing.com – Greece stocks were lower after the close on Monday, as losses in the Telecoms, Banking and Household sectors led shares
By Andres Gonzalez, Christoph Steitz and Emma-Victoria Farr LONDON/FRANKFURT (Reuters) -Berlin has sounded out potential buyers for Uniper in a deal that could
By Jonathan Stempel NEW YORK (Reuters) – A unit of Bank of Montreal agreed to pay $40.7 million to settle U.S. Securities and
By Sam Tobin LONDON (Reuters) – Apple (NASDAQ:AAPL) has abused its dominant position by charging app developers an unfair 30% commission through its
(Reuters) – T-Mobile US (NASDAQ:TMUS) said on Monday it has agreed to acquire Vistar Media, a real-time outdoor advertising technology provider, for
Investing.com — Emerging market (EM) equities remain under pressure, with JPMorgan strategists advising caution despite their underperformance and low valuation metrics. In a note
Investing.com — Shares of Amicus Therapeutics (NASDAQ:FOLD) jumped 9% as the biotech company provided an optimistic preliminary revenue outlook for
